First-in-Human Study of 68Ga-FAP-75 PET Imaging of Cancer-associated Fibroblasts

The novel FAP-targeted probe 68 Ga-FAP-75 exhibits favorable biodistribution, pharmacokinetics, and safety, with good tumor specificity and a favorable tumor-to-background ratio, showing great potential in tumor imaging and radionuclide-targeted therapy.